Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Puthenparampil

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Expert Opinion on Investigational Drugs|December 28, 2023
Bruton tyrosine kinase inhibitors: can they be optimized for the treatment of neuroinflammatory disorders?Andrea Visentin, Marco Puthenparampil, Chiara Briani
BMJ Neurology Open|October 2, 2025
Optic nerve as a 5th location in the revised McDonald diagnostic criteria for multiple sclerosis: limitations of OCT in the acute phaseValentina Annamaria Mauceri, Marco Puthenparampil, Paolo Gallo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2018
PM2.5 levels strongly associate with multiple sclerosis prevalence in the Province of Padua, Veneto Region, North-East ItalyFabio Tateo, Francesca Grassivaro, Mario Ermani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Relapsing tumefactive demyelination lesions: A unique, distinct inflammatory brain pathologyPaola Perini, Marta Gaggiola, Francesca Rinaldi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 1, 2022
Posterior reversible encephalopathy syndrome: an atypical neurological manifestation of SARS-CoV-2 infectionMichela Gasparotto, Marco Puthenparampil, Francesco Morra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 22, 2023
A rare case of Listeria rhombencephalitis with a sudden onset and unusual brain MRI featuresFederica Garrì, Marco Puthenparampil, Davide Simonato, et al.
Multiple Sclerosis and Related Disorders|March 10, 2019
Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature reviewLisa Federle, Marco Puthenparampil, Gianola Stenta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2017
Acute simultaneous development of brain tumour-like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitisMarco Puthenparampil, Alberto Terrin, Lisa Federle, et al.
Frontiers in Immunology|October 24, 2022
Case Report: Para-infectious cranial nerve palsy after bacterial meningitisGiovanni Zanotelli, Lorenzo Bresciani, Mariagiulia Anglani, et al.
Multiple Sclerosis and Related Disorders|September 19, 2018
Herpes simplex virus encephalitis temporally associated with dimethyl fumarate-induced lymphopenia in a multiple sclerosis patientPaola Perini, Francesca Rinaldi, Marco Puthenparampil, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|December 28, 2023
Bruton tyrosine kinase inhibitors: can they be optimized for the treatment of neuroinflammatory disorders?Andrea Visentin, Marco Puthenparampil, Chiara Briani
BMJ Neurology Open|October 2, 2025
Optic nerve as a 5th location in the revised McDonald diagnostic criteria for multiple sclerosis: limitations of OCT in the acute phaseValentina Annamaria Mauceri, Marco Puthenparampil, Paolo Gallo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 2, 2018
PM2.5 levels strongly associate with multiple sclerosis prevalence in the Province of Padua, Veneto Region, North-East ItalyFabio Tateo, Francesca Grassivaro, Mario Ermani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Relapsing tumefactive demyelination lesions: A unique, distinct inflammatory brain pathologyPaola Perini, Marta Gaggiola, Francesca Rinaldi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 1, 2022
Posterior reversible encephalopathy syndrome: an atypical neurological manifestation of SARS-CoV-2 infectionMichela Gasparotto, Marco Puthenparampil, Francesco Morra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 22, 2023
A rare case of Listeria rhombencephalitis with a sudden onset and unusual brain MRI featuresFederica Garrì, Marco Puthenparampil, Davide Simonato, et al.
Multiple Sclerosis and Related Disorders|March 10, 2019
Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature reviewLisa Federle, Marco Puthenparampil, Gianola Stenta, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2017
Acute simultaneous development of brain tumour-like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitisMarco Puthenparampil, Alberto Terrin, Lisa Federle, et al.
Frontiers in Immunology|October 24, 2022
Case Report: Para-infectious cranial nerve palsy after bacterial meningitisGiovanni Zanotelli, Lorenzo Bresciani, Mariagiulia Anglani, et al.
Multiple Sclerosis and Related Disorders|September 19, 2018
Herpes simplex virus encephalitis temporally associated with dimethyl fumarate-induced lymphopenia in a multiple sclerosis patientPaola Perini, Francesca Rinaldi, Marco Puthenparampil, et al.
Pageof 7